| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1248.187 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.187/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187 |
| Version | 20230204 |
| Status | active |
| Date | 2023-02-04T01:02:55-05:00 |
| Name | RoutesOfAdministrationForOpioidAntagonists |
| Title | Routes of Administration for Opioid Antagonists |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for routes of administration for opioid antagonist administration to reverse opioid overdose which includes intranasal spray, inhalation, intramuscular, subcutaneous, or intravenous injection),(Data Element Scope: This value set may use a model element related to routes of medication administrations for opioid antagonists),(Inclusion Criteria: Includes concepts that represent intranasal, intramuscular, intravenous, subcutaneous, inhalation routes of administration for opioid antagonist administration),(Exclusion Criteria: Excludes enteral routes and other routes that are not intranasal, inhalation, intramuscular, intravenous or subcutaneous such as intradermal, intracoronary, intradiscal, intrapulmonary, etc.) |
No resources found
| CodeSystem | |
| sct | SNOMED CT (all versions) |
| sct | SNOMED codes used in this IG |
| sct | veri |
No narrative content found in resource
FHIR